Drugs & TargetsFree Pfizer gets Complete Response Letter for trastuzumab biosimilar April 27, 2018Vol.44 No.17
Drugs & TargetsFree FDA approves Tagrisso for front-line metastatic NSCLC with common EGFR mutations April 20, 2018Vol.44 No.16
Drugs & TargetsFree FDA approves Opdivo and Yervoy for front-line advanced RCC April 20, 2018Vol.44 No.16
Drugs & TargetsFree FDA issues guidance on investigational in vitro diagnostics in oncology trials April 20, 2018Vol.44 No.16
Drugs & Targets Rucaparib approved for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer April 13, 2018Vol.44 No.15
Drugs & Targets FDA finalizes guidances to accelerate development of Next Gen sequencing April 13, 2018Vol.44 No.15
Drugs & Targets MD Anderson, Nanobiotix to collaborate on preclinical research combining NBTXR3, nivolumab April 13, 2018Vol.44 No.15
Drugs & TargetsFree EC expands XGEVA indications for prevention of skeletal events in multiple myeloma April 06, 2018Vol.44 No.14
